Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
-
1221por Zhu, Heng, Wei, Miaoyan, Xu, Jin, Hua, Jie, Liang, Chen, Meng, Qingcai, Zhang, Yiyin, Liu, Jiang, Zhang, Bo, Yu, Xianjun, Shi, Si“…Pancreatic cancer is a highly lethal disease with a poor prognosis, and existing therapies offer only limited effectiveness. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1222“…Additionally, to identify biomarkers on pancreatic cancer cells by blind systematic evolution of ligands by exponential enrichment (SELEX), aptamer pull-down assay and liquid chromatography–tandem mass spectrometry were used. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1223por Bjånes, Tormod, Kotopoulis, Spiros, Murvold, Elisa Thodesen, Kamčeva, Tina, Gjertsen, Bjørn Tore, Gilja, Odd Helge, Schjøtt, Jan, Riedel, Bettina, McCormack, EmmetEnlace del recurso
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1224“…More than eighty percent of pancreatic cancer involves ductal adenocarcinoma with an abundant desmoplastic extracellular matrix surrounding the solid tumor entity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1225por Zhou, Qi, Tao, Xufeng, Xia, Shilin, Guo, Fangyue, Pan, Chen, Xiang, Hong, Shang, Dong“…Pancreatic disorders cause a broad spectrum of clinical diseases, mainly including acute and chronic pancreatitis and pancreatic cancer, and are associated with high global rates of morbidity and mortality. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1226por Tanaka, Yoshinori, Kumagi, Teru, Terao, Takashi, Kuroda, Taira, Yokota, Tomoyuki, Azemoto, Nobuaki, Imamura, Yoshiki, Uesugi, Kazuhiro, Kisaka, Yoshiyasu, Shibata, Naozumi, Koizumi, Mitsuhito, Ohno, Yoshinori, Kanemitsu, Kozue, Yukimoto, Atsushi, Tange, Kazuhiro, Nishiyama, Mari, Miyake, Teruki, Miyata, Hideki, Ishii, Hiroshi, Abe, Masanori, Hiasa, Yoichi“…OBJECTIVE: The long-term effect of the ABO blood type on the clinical course of patients with pancreatic cancer (PC) is inconclusive. This study aimed to determine whether or not the ABO blood type influences the long-term outcomes of PC in Japanese patients. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1227
-
1228por Manero-Rupérez, Noemí, Martínez-Bosch, Neus, Barranco, Luis E., Visa, Laura, Navarro, Pilar“…We also discuss the possible translation of recent results about galectin expression and functions in pancreatic cancer into clinical interventions (i.e., diagnosis, prediction of prognosis and/or therapy) for this fatal disease.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1229por Tomás-Bort, Elena, Kieler, Markus, Sharma, Shreya, Candido, Juliana B, Loessner, Daniela“…In tumor engineering, 3D approaches are used to model components of the tumor microenvironment and to test new treatments. Pancreatic cancers are a cancer of substantial unmet need and survival rates are lower compared to any other cancer. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1230por Wei, Xiaolu, He, Jing, Gao, Bo, Han, Lingyu, Mao, Yingqiu, Zhao, Haiyu, Si, Nan, Wang, Hongjie, Yang, Jian, Bian, Baolin“…It has been shown to be active against Leishmania chagasi promastigotes and Trypanosoma cruzi trypomastigotes and also reported to play an anti-tumor effect on several cancer cell lines in vitro, including pancreatic cancer. This study is aimed to investigate the effects of Hellebrigenin on pancreatic carcinoma cells, SW1990 and BxPC-3 in vitro and its molecular mechanism involved in antitumor activities. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1231por Doleh, Yunes, Lal, Lincy S., Blauer‐Petersen, Cori, Antico, Giovanni, Pishvaian, Michael“…BACKGROUND: Pancreatic cancer represents the third leading cause of US cancer deaths, with median survival <1 year. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1232por Görgülü, Kıvanç, Diakopoulos, Kalliope N., Kaya-Aksoy, Ezgi, Ciecielski, Katrin J., Ai, Jiaoyu, Lesina, Marina, Algül, Hana“…Pancreatic cancer is one of the deadliest cancer types urgently requiring effective therapeutic strategies. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1233“…Thus, we provide an overview of preclinical and clinical efforts of precision medicine in pancreatic cancer.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1234por Stopa, Kinga B., Kusiak, Agnieszka A., Szopa, Mateusz D., Ferdek, Pawel E., Jakubowska, Monika A.“…Pancreatic ductal adenocarcinoma (PDAC) causes annually well over 400,000 deaths world-wide and remains one of the major unresolved health problems. This exocrine pancreatic cancer originates from the mutated epithelial cells: acinar and ductal cells. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1235
-
1236
-
1237por Ishige, Fumitaka, Hoshino, Isamu, Iwatate, Yosuke, Chiba, Satoshi, Arimitsu, Hidehito, Yanagibashi, Hiroo, Nagase, Hiroki, Takayama, Wataru“…Pancreatic cancer is an aggressive tumor associated with poor survival, and early detection is important to improve patient outcomes. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1238
-
1239
-
1240“…Pancreatic cancer (PC) is the utmost stroma-rich cancer, which is accompanied by fibrotic reactions that stimulate interactions between tumor cells and stroma to promote tumor progression. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto